{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:19:27Z","timestamp":1698563967486},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":7890,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1998]]},"DOI":"10.1254\/jjp.78.443","type":"journal-article","created":{"date-parts":[[2002,8,26]],"date-time":"2002-08-26T16:32:11Z","timestamp":1030379531000},"page":"443-454","source":"Crossref","is-referenced-by-count":7,"title":["Heroin Antinociception Changed From Mu to Delta Receptor in Streptozotocin-Treated Mice"],"prefix":"10.1016","volume":"78","author":[{"given":"Rady","family":"Jodie J.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorny","family":"Jennifer M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujimoto","family":"James M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.78.443_bib1","first-page":"383","article-title":"The pharmacologic implications of the fate of morphine and its surrogates","volume":"12","author":"Way","year":"1960","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.78.443_bib2","first-page":"1115","article-title":"Brain uptake of morphine: Pharmacolgical implications","volume":"26","author":"Way","year":"1967","journal-title":"Fed Proc"},{"key":"10.1254\/jjp.78.443_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198405103101902","article-title":"The pharmacokinetics of heroin in patients with chronic pain","volume":"310","author":"Inturrisi","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1254\/jjp.78.443_bib4","first-page":"448","article-title":"Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception","volume":"256","author":"Rady","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0024-3205(94)00486-2","article-title":"Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice","volume":"55","author":"Rady","year":"1994","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib6","first-page":"1222","article-title":"The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss Webster mice","volume":"266","author":"Rady","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pa.32.040192.001323","article-title":"Selective naltrexone-derived opioid receptor antagonists","volume":"32","author":"Takemori","year":"1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1254\/jjp.78.443_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.pa.36.040196.002115","article-title":"Opioid receptor types and subtypes: The \u03b4 receptors as a model","volume":"36","author":"Zaki","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1254\/jjp.78.443_bib9","doi-asserted-by":"crossref","first-page":"PL121","DOI":"10.1016\/0024-3205(94)90062-0","article-title":"Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors","volume":"55","author":"Kamei","year":"1994","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3940(94)90729-3","article-title":"Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors","volume":"165","author":"Kamei","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1254\/jjp.78.443_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(92)90619-K","article-title":"Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice","volume":"576","author":"Kamei","year":"1992","journal-title":"Brain Res"},{"key":"10.1254\/jjp.78.443_bib12","first-page":"318","article-title":"Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine","volume":"218","author":"Simon","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/diab.36.10.1173","article-title":"Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain","volume":"36","author":"Brase","year":"1987","journal-title":"Diabetes"},{"key":"10.1254\/jjp.78.443_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(96)12976-1","article-title":"Novel receptor mechanism for heroin and morphine-6\/9-glucuronide analgesia","volume":"216","author":"Rossi","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1254\/jjp.78.443_bib15","first-page":"89","article-title":"Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence","volume":"298","author":"Vaught","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib16","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0024-3205(82)90558-6","article-title":"Mu and delta receptors: Their role in analgesia and in the differential effects of opioid peptides in analgesia","volume":"30","author":"Vaught","year":"1982","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib17","first-page":"405","article-title":"Beta-FNA binds irreversibly to the opiate receptor complex: In vitro and in vivo evidence","volume":"247","author":"Rothman","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(89)90764-4","article-title":"Modulation of \u03bc-mediated antinociception by \u03b4 agonists in the mouse: Selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin","volume":"165","author":"Heyman","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.78.443_bib19","first-page":"683","article-title":"Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse","volume":"254","author":"Jiang","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib20","first-page":"147","article-title":"Modulation of \u03bc-mediated antinociception in the mouse involves opioid delta-2 receptors","volume":"263","author":"Porreca","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib21","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)10016-4","article-title":"The \u03bc-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia","volume":"324","author":"Sora","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.78.443_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-8993(94)91155-X","article-title":"Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla","volume":"665","author":"Rossi","year":"1991","journal-title":"Brain Res"},{"key":"10.1254\/jjp.78.443_bib23","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D\u2019Amour","year":"1941","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib24","first-page":"435","article-title":"The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tail flick and phenylquinone test","volume":"175","author":"Dewey","year":"1970","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1254\/jjp.78.443_bib25","first-page":"12","article-title":"Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.78.443_bib26","first-page":"166","article-title":"Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains","volume":"265","author":"Pick","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib27","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/0024-3205(91)90155-5","article-title":"Comparison of naloxonazine and \u03b2-funaltrexamine antagonism of \u03bc1 and \u03bc2 opioid actions","volume":"48","author":"Pick","year":"1991","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib28","series-title":"Principles and Procedures of Statistics With Special Reference to the Biological Sciences","first-page":"99","author":"Steel","year":"1960"},{"key":"10.1254\/jjp.78.443_bib29","first-page":"99","article-title":"A simplified method for evaluating dose-eflfect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(92)90167-3","article-title":"A highly selective \u03b41-opioid receptor antagonist: 7-benzylidene-naltrexone","volume":"218","author":"Portoghese","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.78.443_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/jm00397a001","article-title":"Application of the message-address concept in the design of highly potent and selective non-peptide \u03b4 opioid receptor antagonists","volume":"31","author":"Portoghese","year":"1988","journal-title":"J Med Chem"},{"key":"10.1254\/jjp.78.443_bib32","first-page":"235.6","article-title":"Heroin and M6G analgesia are retained in mu opioid receptor deficient mice","volume":"23","author":"Schuller","year":"1997","journal-title":"Soc Neurosci Abst"},{"key":"10.1254\/jjp.78.443_bib33","first-page":"235.7","article-title":"Selective blockade of heroin but not traditional mu, delta, and kappa analgesia by 3-methoxy-naltrexone","volume":"23","author":"Brown","year":"1997","journal-title":"Soc Neurosci Abstr"},{"key":"10.1254\/jjp.78.443_bib34","first-page":"890","article-title":"Differential contribution of descending serotonergic and noradrenergic systems to ceatral Tyr-D-Ala2-Gly-NmePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice","volume":"256","author":"Arts","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.78.443_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(92)90619-K","article-title":"Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice","volume":"576","author":"Kamei","year":"1992","journal-title":"Brain Res"},{"key":"10.1254\/jjp.78.443_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(93)90267-O","article-title":"The effects of cyclosporine on morphine-induced antinociception in diabetic mice","volume":"158","author":"Kamei","year":"1993","journal-title":"Neursoci Lett"},{"key":"10.1254\/jjp.78.443_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0024-3205(93)90281-7","article-title":"The combined immunological and antinociceptive defects of beige-J mice: The possible existence of a \u201c\u03bc-repressin\u201d","volume":"52","author":"Raflfa","year":"1993","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0024-3205(88)90554-1","article-title":"The analgesic deficit of C57BL\/6J-bgJ\/bgJ (Beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermates","volume":"42","author":"Raflfa","year":"1988","journal-title":"Life Sci"},{"key":"10.1254\/jjp.78.443_bib39","first-page":"603","article-title":"Morphine antinociception in different strains of mice: Relationship of supraspinal multiplicative interaction to tolerance","volume":"247","author":"Roerig","year":"1988","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002151981931008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002151981931008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjp\/78\/4\/78_4_443\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:24:40Z","timestamp":1605637480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002151981931008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998]]}},"alternative-id":["S002151981931008X"],"URL":"https:\/\/doi.org\/10.1254\/jjp.78.443","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1998]]}}}